Beta-L-2'-Deoxy Nucleosides for the Treatment of Hepatitis B
Details for Australian Patent Application No. 2004201286 (hide)
International Classifications
Event Publications
22 April 2004 Complete Application Filed
6 May 2004 Application Open to Public Inspection
Published as AU-B-2004201286
21 June 2007 Amendment Made
The nature of the amendment is: Amend co-inventor names to read Imbach, JeanLouis; Gosselin, Gilles and Bryant, Martin L
21 June 2007 Application Accepted
Published as AU-B-2004201286
18 October 2007 Standard Patent Sealed
12 January 2012 Assignment Registered
L'Universite Montpellier II; Centre National de la Recherche Scientifique (CNRS); Idenix (Cayman) Limited The patent has been assigned to L'Universite Montpellier II; Centre National de la Recherche Scientifique (CNRS); Idenix Pharmaceuticals, Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004201287-Soluble CTLA4 mutant molecules and uses thereof
2004201285-Tissue-specific and target RNA-specific ribozymes
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser